Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and there was plenty of high-conviction activity this week.
Here’s the most notable activity:
First up is MSCI Inc $MSCI, where the Chairman & CEO just bought over $6.7 million worth of shares.
That’s a big swing, even for a CEO — a clear signal that he likes what he sees ahead for the capital markets leader.
Over at Sonos $SONO, Coliseum Capital isn’t slowing down. They just added nearly $15 million to their position.
They’ve been pounding the table on this one for a while, and this move only bolsters and confirms what was already a bullish view.
Newegg $NEGG had to make our list again as Vladimir Galkin continues his buying spree — he’s now spent around $30 million in the past two weeks.
Biotechs are quietly gaining momentum — and this week’s filings back that up.
Paradigm Biocapital Advisors reported a brand new 5.60% stake in Cidara Therapeutics $CDTX.
And here's another from last week with Point72 showing up in Replimune $REPL with a fresh 5.70% stake. That’s Steve Cohen’s firm stepping into a name right as sentiment is turning for the entire group.
I expect to see a lot more biotech activity from the hedge fund space in the future, and will be looking to ride the best trends alongside these insiders.
If you're not a member of Hot Corner Insider and want access to exclusive trade ideas, weekly conference calls, and deep dive reports, join us risk-free.
